BATM Advanced Communications Ltd. (LSE: BVC)

About BATM Advanced Communications Ltd.

BATM Advanced Communications Ltd., together with its various group companies, delivers cutting-edge real-time technologies for both sophisticated networking solutions and advanced biomedical systems. The company operates across Israel, the United States, and Europe. It is structured into two primary business units: Networking and Cyber, and Bio-Medical. The Networking and Cyber division oversees the research, development, manufacturing, and marketing of data communication products. Its key offerings include network function virtualization, carrier Ethernet and MPLS access technologies, and systems for cyber network monitoring. This segment also provides a range of software services, such as training, technical assistance, and laboratory maintenance, in addition to undertaking construction contracts. Conversely, the Bio-Medical division concentrates on the innovation, production, commercialization, and distribution of medical products, with a particular emphasis on laboratory diagnostics and sterilization equipment. Its portfolio features molecular biology diagnostic tools and specialized systems for managing pathogenic and medical waste in critical environments like laboratories, hospitals, pharmaceutical manufacturing plants, and agricultural settings. This division also acts as a distributor for a broad array of diagnostic apparatus and medical consumables from various manufacturers. Notably, BATM has entered into a significant partnership with Novamed Ltd to collaboratively develop and market a home-use testing kit for COVID-19. Established in 1992, the company's corporate headquarters are situated in Hod Hasharon, Israel.

ISIN

IL0010849045

Founded

1992

Listed since

Nov 11, 1999

Exchange

London Stock Exchange

Currency

GBP